| Product Information |
|
| Registration Number |
BR-415
|
| Generic Name |
Measles, Mumps, Rubella (MMR) Vaccine (Live, attenuated) [see formulation on reverse side]
|
| Brand Name |
Priorix
|
| Dosage Strength |
After reconstitution, each dose (0.5mL) contains:
Measles virus (Schwarz strain), live attenuated NLT 10 3.0 CCID 50
Mumps virus (RIT4385 strain), live attenuated NLT 10 3.7 CCID 50
Rubella virus (Wistar RA 27/3 strain), live attenuated NLT 10 3.0 CCID 50
|
| Dosage Form |
Powder for Solution for Injection (SC)
|
| Classification |
Prescription Drug (Rx)
|
| Packaging |
Each box contains: 3 mL Clear Glass Vial (Type I, Ph. Eur.) fitted with bromobutyl rubber stopper, aluminum overcap and flip-off cap; Type I glass syringes stoppered with a plunger stopper (diluent); 2 sterile needles (25G x 5/8") [Box of 1's and 100's]
|
| Pharmacologic Category |
-
|
| Manufacturer |
GSK Biologicals SA
|
| Country of Origin |
Belgium
|
| Trader |
|
| Importer |
GlaxoSmithKline Philippines, Inc.
|
| Distributor |
|
| Application Type |
-
|
| Issuance Date |
30 March 2021
|
| Expiry Date |
04 May 2026
|